← Back to headlines
Vertex Pharmaceuticals Invests $10 Billion in Crinetics
Vertex Pharmaceuticals is making a significant $10 billion investment in Crinetics, aiming to establish a leading position in the endocrinology sector.
11 Jul, 21:02 — 11 Jul, 21:02
Sources
Showing 1 of 1 sources
